Intra-Cellular Therapies
ITCI
#2214
Rank
$6.69 B
Marketcap
$69.20
Share price
-0.75%
Change (1 day)
24.17%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2023 (TTM): -$0.14 B

According to Intra-Cellular Therapies's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2022 the company made an earning of -$0.26 B an increase over its 2021 earnings that were of -$0.29 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)-$0.14 B-45.74%
2022-$0.26 B-9.81%
2021-$0.29 B25.17%
2020-$0.23 B53.66%
2019-$0.15 B-4.77%
2018-$0.16 B56.96%
2017-$98.84 M-14.33%
2016-$0.12 B10.09%
2015-$0.11 B241.45%
2014-$30.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.13 B-13.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.57 M-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$43.93 M-68.41%๐Ÿ‡บ๐Ÿ‡ธ USA